Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05069857
What this trial is testing

Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients

Who this might be right for
Oral Squamous Cell CarcinomaNeoadjvant TherapyAnti-PD-1+1 more
Shanghai Jiao Tong University School of Medicine 46
Testing effectiveness (Phase 2)UnknownNCT03784066
What this trial is testing

Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Universitaire Ziekenhuizen KU Leuven 21
Testing effectiveness (Phase 2)UnknownNCT05351762
What this trial is testing

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Xijing Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT06509568
What this trial is testing

Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 92
Testing effectiveness (Phase 2)Looking for participantsNCT07371234
What this trial is testing

Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Rui You 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06588335
What this trial is testing

BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT06952621
What this trial is testing

Neoadjuvant Treatment of Toripalimab Combined With Nab-paclitaxel and Platinum Versus Neoadjuvant Docetaxel Combined With Cisplatin and 5-fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital 390
Early research (Phase 1)UnknownNCT03843515
What this trial is testing

Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Amsterdam UMC, location VUmc 17
Testing effectiveness (Phase 2)Looking for participantsNCT07266493
What this trial is testing

Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Shanghai Zhongshan Hospital 26
Testing effectiveness (Phase 2)UnknownNCT06023875
What this trial is testing

Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaLocally Advanced Operable
Xuekui Liu 30
Very early researchEnded earlyNCT04630353
What this trial is testing

A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer

Who this might be right for
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
AstraZeneca 10